freestyle libre flash glucose monitoring device

This is an ERS International Congress abstract. This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the 'pre COVID-19' era”. However, there was no difference in the frequency of infective exacerbations as the difference of mean was not significant with P value of 0.24.Ĭonclusion: Flash glucose monitoring significantly improves blood glucose control in CFRD.Ĭite this article as: European Respiratory Journal 2020 56: Suppl. The difference of mean for HbA1c is 6.5 mmol/mol in patients with CFRD (p=0.006) with 95% CI.

Results: We observed a significant improvement in HbA1c levels following the use of Freestyle Libre sensor monitoring. We further assessed the impact of flash glucose monitoring system on lung health by comparing the number of infective exacerbations requiring intravenous antibiotics in the 6 months prior and 6 months after starting to use the FreeStyle Libre sensor in patients with CFRD. HbA1c values prior to and at least 3-6 months after starting to use the FreeStyle libre sensor were compared and statistical analysis was undertaken (paired t-test). In addition, these 30 patients regularly upload their data to a central data storage programme Libre view. Of these, 30 patients have HbA1c measurements within 12 months prior to and 6 months after starting with the flash blood glucose monitoring. The FreeStyle Libre 2 system automatically tracks your glucose levels day and night using a small sensor worn on the back of the upper arm and an app or. Method: Since April 2019, 62 patients with CFRD in our centre were registered to use Libre sensors. The aims of our study were firstly to evaluate whether there is an improvement in blood glucose control in patients with FreeStyle Libre sensor monitoring, and secondly whether this has an impact on the frequency of infective respiratory exacerbations in patients with CFRD. What is the FreeStyle Libre system The FreeStyle Libre flash glucose monitoring system comprises a Sensor and a Reader. Objective: In the UK, flash glucose monitoring system (Freestyle Libre sensor) has been made available to patients with cystic fibrosis related diabetes (CFRD).

Freestyle libre flash glucose monitoring device